Health Care & Life Sciences » Pharmaceuticals | Otsuka Holdings Co. Ltd.

Otsuka Holdings Co. Ltd. | Income Statement

Fiscal year is January-December. All values JPY Millions.
2014
2015
2016
2017
2018
Sales/Revenue
1,452,759
1,427,375
1,195,746
1,239,952
1,291,981
Cost of Goods Sold (COGS) incl. D&A
462,241
452,466
406,331
422,412
441,832
Gross Income
990,518
974,909
789,415
817,540
850,149
SG&A Expense
791,816
839,147
704,980
704,861
745,231
EBIT
198,702
-
84,435
112,679
104,918
Unusual Expense
5,210
4,333
7,270
27,847
10,398
Non Operating Income/Expense
13,498
950
25,679
1,943
206
Interest Expense
1,237
4,820
4,143
4,338
3,685
Pretax Income
210,225
137,929
100,706
103,712
109,497
Income Tax
57,672
50,919
23,347
10,674
24,101
Equity in Affiliates
-
12,370
15,974
-
-
Consolidated Net Income
152,553
99,380
93,332
114,387
85,395
Net Income
150,989
101,957
92,563
112,492
82,492
Net Income After Extraordinaries
150,989
101,957
92,563
112,492
82,492
Net Income Available to Common
150,955
101,957
92,563
112,492
82,492
EPS (Basic)
278.07
188.17
170.83
207.61
152.24
Basic Shares Outstanding
543
542
542
542
542
EPS (Diluted)
277.52
188.15
170.70
207.00
151.26
Diluted Shares Outstanding
543
542
542
542
542
EBITDA
248,447
194,918
144,009
174,914
164,193
Other Operating Expense
-
-
-
-
-
Non-Operating Interest Income
1,251
1,703
2,008
1,966
1,948
Minority Interest Expense
1,564
2,577
769
1,895
2,903
Equity in Affiliates (Pretax)
3,221
-
-
19,307
16,508
Preferred Dividends
34
-
-
-
-

About Otsuka Holdings Co.

View Profile
Address
Shinagawa Grand Central Tower, 12/F
Tokyo Tokyo 108
Japan
Employees -
Website http://www.otsuka.com
Updated 07/08/2019
Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following businesses: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals business manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases.